NCT00668343View on ClinicalTrials.gov

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2009

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

simvastatin

40 mg/ day

DRUG

placebo

80 mg /day

Trial Locations (1)

0098

Sanaz Ahmadi, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT00668343 - Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo | Biotech Hunter | Biotech Hunter